Clinical Trials on Carcinoma, Ovarian Epithelial
Total 30445 results
-
Grupo Español de Investigación en Cáncer de OvarioCompletedPlatinum-resistant Advanced Ovarian CancerSpain
-
Grupo Español de Investigación en Cáncer de OvarioRoche Pharma AGTerminated
-
Imperial College LondonGlaxoSmithKlineCompletedOvarian NeoplasmUnited Kingdom
-
University Hospital, Basel, SwitzerlandWithdrawnEndometriosis | Endometrioid Carcinoma | Clear Cell Carcinoma
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian... and other conditionsUnited States
-
Shanghai Gynecologic Oncology GroupFudan University; Shanghai Zhongshan Hospital; Shanghai Jiao Tong University...CompletedFallopian Tube Cancer | Primary Peritoneal Carcinoma | Bulky Stage IIIC and IV Epithelial Ovarian CancerChina
-
Lei LiRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound PaclitaxelChina
-
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.RecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerChina
-
ImmunoGen, Inc.Gynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Canada, Germany, China, France, Korea, Republic of, Belgium, United Kingdom, Serbia, Spain, Australia, Israel, Italy, Taiwan, Czechia, Bulgaria, Netherlands, Portugal, Poland, Russian Federation, Ukraine
-
Duke UniversityCompletedFallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer, EpithelialUnited States
-
Asan Medical CenterUnknownEpithelial Ovarian CancerKorea, Republic of
-
University of British ColumbiaGenzyme, a Sanofi CompanyTerminatedEpithelial Ovarian CancerCanada, United States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Norway
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Epithelial Cancer | Stage I Ovarian Epithelial Cancer | Stage II Ovarian Epithelial CancerUnited States
-
Daiichi Sankyo, Inc.CompletedOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
SanofiCompletedPrimary Peritoneal Cancer | Advanced Epithelial Ovarian CancerUnited States
-
AGO Research GmbHHoffmann-La RocheActive, not recruitingRecurrent Ovarian CarcinomaNorway, Spain, France, Switzerland, Denmark, Germany, Sweden, Belgium, Finland, Austria, Estonia, Lithuania
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedMaveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer (AVALON)Platinum-resistant Epithelial Ovarian CancerUnited States, Canada, Puerto Rico
-
AGO Study GroupPhilipps University Marburg Medical Center; HSK Reasearch GmbH WiesbadenCompletedPlatinum Refractory Epithelial Ovarian Cancer | Primary Cancer of the Peritoneum | Cancer of the Fallopian TubeGermany
-
University of WashingtonNational Cancer Institute (NCI)CompletedCaregiver | Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian CancerUnited States
-
EpicentRx, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Ovarian Epithelial Cancer | Neuroendocrine Tumors | Small Cell CarcinomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingOvarian Carcinoma | High-grade Serous Ovarian CarcinomaKorea, Republic of, Spain, Poland, United States, Belgium, Canada, Chile, Israel, Italy, Singapore, Taiwan
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.RecruitingAdvanced Ovarian CancerChina
-
Tesaro, Inc.Completed
-
PharmaMarCompletedRelapsed Ovarian CancerSpain, France, Italy, Belgium, Germany
-
Immetacyte LtdWithdrawnOvarian Cancer MetastaticUnited Kingdom
-
Yonsei UniversityCompletedAdvanced-stage Ovarian CancerKorea, Republic of
-
Inge Marie SvaneCompleted
-
AbbVie (prior sponsor, Abbott)BiogenCompletedOvarian Cancer, Primary Peritoneal CancerUnited States, Australia, Belgium, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland
-
Yonsei UniversityRecruitingRecurrent Epithelial Ovarian CancerKorea, Republic of
-
Andrea JewellUniversity of Kansas Medical CenterRecruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian CancerUnited States
-
ARCAGY/ GINECO GROUPActive, not recruitingEpithelial Ovarian Cancer | RelapseFrance
-
AGO Study GroupCompletedOvarian Cancer | Fallopian Tube CancerGermany
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
University Health Network, TorontoCompletedStage IV Ovarian Cancer | Stage III Ovarian CancerCanada
-
Yonsei UniversityNational Cancer Center, Korea; Samsung Medical Center; AstraZeneca; Seoul National... and other collaboratorsUnknownOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
Seoul National University HospitalPharos iBio Co., Ltd.RecruitingPlatinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-refractory Ovarian CarcinomaKorea, Republic of
-
Azaya Therapeutics, Inc.UnknownCancer | Ovarian Cancer | Ovarian Epithelial Cancer Recurrent | Malignant Female Reproductive System Neoplasm | Ovarian TumorCanada, United States
-
Turku University HospitalRecruitingHypoxia | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CarcinomaFinland
-
Krankenhaus Barmherzige Schwestern LinzWithdrawnFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerAustria
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingPatients With Suspected Ovarian Carcinoma | Non Oncological Patients or With EndometriosisItaly
-
Menoufia UniversityWithdrawnOvarian Cancer | Recurrent Ovarian CarcinomaEgypt
-
Glycotope GmbHCompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Epithelial Cancer RecurrentGermany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)RecruitingStage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian CancerUnited States
-
Azienda Ospedaliera di PadovaUniversity of PadovaRecruiting
-
The First Affiliated Hospital of Xiamen UniversityRecruitingOvarian CancerChina